PubRank

Mohamed Bejaoui

Author PubWeight™ 27.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 2005 6.07
2 X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006 2.18
3 Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood 2011 1.23
4 Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 2013 1.22
5 Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003 1.17
6 Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 2011 1.09
7 Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther 2007 1.06
8 AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res 2013 0.98
9 Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr 2006 0.96
10 High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol 2012 0.96
11 Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis 2013 0.95
12 Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci 2011 0.87
13 Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol 2013 0.86
14 Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int 2014 0.85
15 Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis 2007 0.83
16 Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol 2003 0.79
17 Autoimmune polyglandular syndrome type II after bone marrow transplant: real transfer or acceleration of a programmed disease? Exp Clin Transplant 2012 0.78
18 Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in Tunisia. C R Biol 2013 0.78
19 Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome). Clin Mol Allergy 2012 0.77
20 [Deficient expression of leukocyte adhesion proteins. A new Tunisian case]. Tunis Med 2006 0.77
21 Omenn syndrome: two case reports. Acta Dermatovenerol Croat 2013 0.76
22 Anti-thrombomodulin antibodies and venous thrombosis. Blood Coagul Fibrinolysis 2004 0.76
23 Contribution to the description of the beta-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin 2004 0.76
24 Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons. Dig Dis 2015 0.76
25 Correction: Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One 2015 0.75
26 Hypocalcaemia due to hypoparathyroidism in β-thalassemia major. A study of a new case. Tunis Med 2011 0.75
27 Primary immunodeficiencies : Report of 33 Pediatric Tunisian cases. Tunis Med 2016 0.75
28 Cytogenetic assessment of Fanconi anemia in children with aplastic anemia in Tunisia. J Pediatr Hematol Oncol 2013 0.75
29 Salmonella enteriditis inducing cutaneous leucocytoclasic vasculitis: An unusual complication in a patient with an interleukine- 12 receptor beta-1 deficiency. Tunis Med 2015 0.75
30 Budd-Chiari syndrome in a boy with β thalassemia major (a study of a new case). J Pediatr Hematol Oncol 2013 0.75
31 [A congenital deficiency of the C3 fraction of complement. A familial study]. Tunis Med 2003 0.75
32 Successful treatment of mycophenolate mofetil in a child with refractory Evans syndrome. J Pediatr Hematol Oncol 2010 0.75
33 Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report. Pediatr Transplant 2007 0.75
34 [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases]. Tunis Med 2013 0.75
35 [Pulmonary aspergillosis in a child with chronic granulomatous disease]. Tunis Med 2003 0.75
36 [Bronchopulmonary aspergillosis: study of 17 cases]. Tunis Med 2002 0.75